27 Jan 2014 14:00
ViaLogy plc ("ViaLogy" or "the Company")
Result of General Meeting
ViaLogy is pleased to announce that at a General Meeting of the Company held earlier today, all resolutions were duly passed.
Further to the announcements of 7 January 2014 and 24 January 2014, ViaLogy has raised, via a Placing of 1,100,000,000 Ordinary Shares at 0.1p per share, £1.1 million (before expenses), and an additional £519,820 via an oversubscribed Open Offer to existing shareholders through the issue of 519,820,122 Ordinary Shares at 0.1p per share.
The Open Offer and Placing have therefore raised a total of £1,619,820 (before expenses). Application has been made for the admission of 1,649,820,122* Ordinary Shares of 0.1p each (following the Capital Reorganisation) to trading on AIM ("Admission") and dealings are expected to commence in these new shares on Tuesday 28 January 2014.
Following Admission, the Company shall have 2,689,460,366 ordinary shares of 0.1p in issue, which figure may be used after Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.
Following their participation in the Placing and Open Offer, the following Directors of ViaLogy have an interest in the Ordinary Share Capital of the Company as follows:
Director | Current Holding | Placing Participation | Open Offer Entitlement | Total Holding | % Holding |
Adam Reynolds | Nil | 75,000,000 | Nil | 75,000,000 | 2.79 |
Dr. Robert Dean | 2,897,304 | Nil | 1,448,652 | 4,345,956 | 0.17 |
Dr. Sandeep Gulati | 6,904,412 | Nil | 3,912,184 | 10,816,596 | 0.41 |
Nicholas Mustoe | Nil | 150,000,000 | Nil | 150,000,000 | 5.58 |
Capitalised terms used in this announcement are as defined in the shareholder circular dated 7 January 2014.
*includes 30,000,000 ordinary shares of 0.1peach being issued as part consideration for fees relating to Corporate Finance advice
For further information:
ViaLogy PLC
Mark Collingbourne mark.collingbourne@vialogy.com
Nominated Advisor to ViaLogy PLC (Cantor Fitzgerald Europe)
Mark Percy / Catherine Leftley - Corporate Finance +44 (0) 207 894 7000